ARES MANAGEMENT LLC purchased $2.9M of CTEV (indirect holdings)

ARES MANAGEMENT LLC purchased 115,579 indirectly-held shares of Claritev Corp (CTEV) at an average of $25.40 ($24.42–$26.14, $2.94M total) across 2 trades over 2026-11-09 to 2026-11-10. Filed jointly with ASOF Investment Management LLC (10% owner), Ares Management Holdings L.P. (10% owner), Ares Holdco LLC (10% owner), Ares Management Corp (10% owner), Ares Voting LLC (10% owner), Ares Management GP LLC (10% owner) and Ares Partners Holdco LLC (10% owner).

Original reporting
SEC EDGAR · ARES MANAGEMENT LLC, ASOF Investment Management LLC, Ares Management Holdings L.P., Ares Holdco LLC, Ares Management Corp, Ares Voting LLC, Ares Management GP LLC, Ares Partners Holdco LLC
Published Nov 12, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CTEV
Bullish
medium confidence
Mentioned
$CTEV
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTEVBullishLow
01

Why it matters

The disclosed purchase adds to the insider ownership base, potentially reducing float and supporting price stability.

02

Market read

The filing is a primary source of new information for Claritev Corp, offering a modest trading cue for short‑term investors.

03

What to watch

Potential upcoming dilution, pending regulatory approvals, or sector‑wide headwinds that could offset the positive signal from insider buying.

Relevance 7/10Novelty 6/10Timing: filing date 2026-11-12

Background

Form 4 filings provide transparent disclosure of insider transactions, which traders monitor for signals of confidence or concern.

Company-level read

Ticker impact

$CTEVBullishMedium confidence
Context

SEC Form 4 disclosed ARES MANAGEMENT LLC purchased $2.9M of Claritev Corp shares, increasing its stake to 2,049,518 shares.

Expected impact

likely upward pressure as the market prices in the insider buying.

Evidence & confidence

A 10% owner buying additional shares at $25.40 average price is a material insider transaction for a micro‑cap, suggesting bullish sentiment.

Market effects

Minimal; the transaction is company‑specific and does not affect the broader sector.

None; the filing is a US SEC disclosure with no regional macro implications.

Low; only relevant to investors tracking Claritev Corp.

Counterpoint

The purchase could be a strategic move unrelated to fundamentals, and the stock may still face downside pressure if broader market sentiment turns negative.

Key entities

  • Claritev Corp

    Issuer of the shares purchased.

  • ARES MANAGEMENT LLC

    Insider reporting a $2.9M purchase of Claritev shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTEVLow

ARES MANAGEMENT LLC purchased $1.7M of CTEV (indirect holdings)

ARES MANAGEMENT LLC purchased 70,834 indirectly-held shares of Claritev Corp (CTEV) at an average of $23.69 ($23.53–$24.07, $1.68M total) across 2 trades over 2026-10-23 to 2026-10-26. Filed jointly with ASOF Investment Management LLC (10% owner), Ares Management Holdings L.P. (10% owner), Ares Holdco LLC (10% owner), Ares Management Corp (10% owner), Ares Voting LLC (10% owner), Ares Management GP LLC (10% owner) and Ares Partners Holdco LLC (10% owner).

$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

$CTEVMed

Claritev Corporation Reports Second Quarter 2026 Results

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202